Withholding initial vancomycin in febrile neutropenia despite implanted catheters.
Berger
Christoph
C
Division of Infectious Diseases, University Childrens Hospital, Steinwiesstrasse 75, 8032 Zurich, Switzerland. Christoph.Berger@kispi.unizh.ch
Kindli
Karin
K
Niggli
Felix K
FK
Nadal
David
D
D000293:Adolescent; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D024881:Drug Resistance, Bacterial; D005334:Fever / Q000150:complications; D006801:Humans; D007223:Infant; D000077731:Meropenem; D009369:Neoplasms / Q000150:complications; D009503:Neutropenia / Q000150:complications; D011446:Prospective Studies; D013845:Thienamycins / Q000008:administration & dosage / Q000627:therapeutic use; D014640:Vancomycin / Q000008:administration & dosage / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D013845:Thienamycins; D014640:Vancomycin; D000666:Amphotericin B; D000077731:Meropenem